UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Commault Systems
CVLT
$5.61B
| $14.5M | ﹤0.01% |
115,912
-247,105
| -68% | -$34.8M |
|
|
DLY
2902
DoubleLine Yield Opportunities Fund
DLY
$690M
| $14.5M | ﹤0.01% |
998,867
-13,148
| -1% | -$193K |
|
2903
PUT
Enphase Energy
ENPH
$5.53B
| $14.5M | ﹤0.01% |
451,900
+97,500
| +28% | +$3.16M |
|
2904
Enpro
NPO
$7.05B
| $14.5M | ﹤0.01% |
67,572
+23,705
| +54% | +$5.24M |
|
2905
Pacira BioSciences
PCRX
$997M
| $14.5M | ﹤0.01% |
558,651
-296,210
| -35% | -$7.04M |
|
2906
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$735M
| $14.4M | ﹤0.01% |
294,971
+19,183
| +7% | +$922K |
|
2907
Corcept Therapeutics
CORT
$12B
| $14.4M | ﹤0.01% |
414,851
-135,087
| -25% | -$10.6M |
|
2908
CALL
Amgen
AMGN
$222B
| $14.4M | ﹤0.01% |
44,088
+1,288
| +3% | +$409K |
|
2909
Hilton Grand Vacations
HGV
$3.55B
| $14.4M | ﹤0.01% |
322,467
-1,935,924
| -86% | -$82.2M |
|
2910
Vishay Intertechnology
VSH
$5.43B
| $14.4M | ﹤0.01% |
995,668
+630,917
| +173% | +$9.56M |
|
2911
iShares Cybersecurity and Tech ETF
IHAK
$1.1B
| $14.4M | ﹤0.01% |
299,688
-1,121
| -0.4% | -$56.6K |
|
2912
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.77B
| $14.4M | ﹤0.01% |
151,957
-58,310
| -28% | -$5.54M |
|
2913
Fortune Brands Innovations
FBIN
$6.06B
| $14.4M | ﹤0.01% |
287,881
-132,507
| -32% | -$6.65M |
|
2914
Par Pacific Holdings
PARR
$3.32B
| $14.4M | ﹤0.01% |
409,776
+159,399
| +64% | +$6.34M |
|
2915
First Bancorp
FBP
$4.38B
| $14.4M | ﹤0.01% |
693,892
-449,363
| -39% | -$9.26M |
|
2916
ACI Worldwide
ACIW
$5.42B
| $14.3M | ﹤0.01% |
299,135
+70,401
| +31% | +$3.42M |
|
2917
RingCentral
RNG
$5.28B
| $14.2M | ﹤0.01% |
493,387
+147,019
| +42% | +$4.19M |
|
2918
PUT
Archer Daniels Midland
ADM
$36.9B
| $14.2M | ﹤0.01% |
247,800
| – | – |
|
2919
CALL
Sysco
SYY
$40.3B
| $14.2M | ﹤0.01% |
193,100
| – | – |
|
2920
Ambev
ABEV
$46.4B
| $14.2M | ﹤0.01% |
5,758,217
-229,987
| -4% | -$548K |
|
2921
FTI Consulting
FCN
$4.18B
| $14.2M | ﹤0.01% |
83,244
-23,248
| -22% | -$3.83M |
|
2922
New Mountain Finance
NMFC
$732M
| $14.2M | ﹤0.01% |
1,541,128
+385,891
| +33% | +$3.64M |
|
2923
KBR
KBR
$4.8B
| $14.2M | ﹤0.01% |
352,719
-167,868
| -32% | -$7.2M |
|
2924
PUT
Tenet Healthcare
THC
$21.1B
| $14.2M | ﹤0.01% |
71,300
| – | – |
|
|
EVMO
2925
Eaton Vance Mortgage Opportunities ETF
EVMO
$863M
| $14.2M | ﹤0.01% |
278,966
-12,016
| -4% | -$610K |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.